Correction: Clinical impact of PD-L1 expression in triple-negative breast cancer patients with residual tumor burden after neoadjuvant chemotherapy

• Gizem Oner,
• Semen Önder,
• Hüseyin Karatay,
• Naziye Ak,
• Mustafa Tükenmez,
• Mahmut Müslümanoğlu,
• Abdullah İğci,
• Ahmet Dincçağ,
• Vahit Özmen,
• Adnan Aydiner,
• Ekrem Yavuz,
• Neslihan Cabioğlu

Affiliations

Gizem Oner

Department of General Surgery, Istanbul Faculty of Medicine, Istanbul University

Semen Önder

Department of Pathology, Istanbul Faculty of Medicine, Istanbul University

Hüseyin Karatay

Department of Pathology, Istanbul Faculty of Medicine, Istanbul University

Naziye Ak

Department of Medical Oncology, Institute of Oncology, Istanbul University

Mustafa Tükenmez

Department of General Surgery, Istanbul Faculty of Medicine, Istanbul University

Mahmut Müslümanoğlu

Department of General Surgery, Istanbul Faculty of Medicine, Istanbul University

Abdullah İğci

Department of General Surgery, Istanbul Faculty of Medicine, Istanbul University

Ahmet Dincçağ

Department of General Surgery, Istanbul Faculty of Medicine, Istanbul University

Vahit Özmen

Department of General Surgery, Istanbul Faculty of Medicine, Istanbul University

Adnan Aydiner

Department of Medical Oncology, Institute of Oncology, Istanbul University

Ekrem Yavuz

Department of Pathology, Istanbul Faculty of Medicine, Istanbul University

Neslihan Cabioğlu

Department of General Surgery, Istanbul Faculty of Medicine, Istanbul University